Davis Polk deal named “Impact Deal of the Year” at 2023 LMG Life Sciences Americas Awards
Davis Polk was honored in connection with its role advising on ACELYRIN’s $621 million IPO, which was named an “Impact Deal of the Year – United States” at the 2023 LMG Life Sciences Americas Awards. Davis Polk advised the joint book-running managers in connection with the upsized initial public offering.
The LMG Life Sciences Americas Awards recognize leading life sciences practitioners and firms the United States and Canada providing excellent legal service over a 12-month period. The awards were presented on September 7, 2023, in New York.
Learn more here.